Doctor profile · Federal record
Dr. Asha Karippot, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Plano, TX
- NPI 1841485216
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 24 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4708 Alliance Blvd Ste 150
Plano, TX 750935339
(972) 596-7801
fax (972) 596-9307 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- September 2007 — 19 yrs on file
- Profile last updated
- September 23, 2022
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Texas #Q1635 · Oklahoma #33176
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841485216. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
134,142
Distinct HCPCS
10
Medicare allowed
$1,780,165
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 29,580 | 37 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 19,500 | 22 | $54 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,067 | 110 | $0 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 11,040 | 13 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 9,000 | 23 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 7,810 | 13 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 6,756 | 17 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,225 | 17 | $3 | |
J1453 |
Injection, fosaprepitant, 1 mg | 5,550 | 14 | $0 | |
J9041 |
Injection, bortezomib, 0.1 mg | 4,585 | 15 | $5 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 1,308. This provider delivers 103× the peer median.Open Payments
Industry payments received
All-time total
$532
Transactions
30
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $163.32 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $77.58 | |
| ABBVIE INC. | 4 | $75.33 | |
| Merck Sharp & Dohme LLC | 3 | $58.84 | |
| Gilead Sciences, Inc. | 2 | $45.26 | |
| Kite Pharma, Inc. | 2 | $40.30 | |
| AstraZeneca Pharmaceuticals LP | 1 | $23.68 | |
| Sirtex Medical Inc | 1 | $16.74 | |
| GENZYME CORPORATION | 1 | $16.27 | |
| Secura Bio, Inc. | 1 | $14.79 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
485
Patients
118
Total drug cost
$39,661
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 93 | 23 | $3,634 |
| Tamoxifen Citrate | Generic | 63 | 11 | $2,147 |
| Potassium Chloride | Generic | 39 | 16 | $465 |
| Mirtazapine | Generic | 37 | 0 | $318 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 33 | 16 | $902 |
| Eliquis (Apixaban) | Brand | 31 | 0 | $18,413 |
| Prochlorperazine Maleate | Generic | 30 | 18 | $519 |
| Ondansetron Odt (Ondansetron) | Brand | 27 | 20 | $277 |
| Dexamethasone | Generic | 23 | 14 | $144 |
| Gabapentin | Generic | 22 | 0 | $85 |
Hospital affiliations
Frequently asked questions
What is Dr. Asha Karippot's medical specialty?
Dr. Asha Karippot practices Hematology & Oncology Physician in Plano, TX.
Where does Dr. Asha Karippot practice?
Dr. Asha Karippot practices at 4708 Alliance Blvd Ste 150, Plano, TX 750935339. Office phone: 9725967801.
What is Dr. Asha Karippot's NPI?
Dr. Asha Karippot's National Provider Identifier (NPI) is 1841485216, issued by NPPES.
Does Dr. Asha Karippot accept Medicare assignment?
Yes. Dr. Asha Karippot accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Asha Karippot commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967). Source: CMS Medicare Physician & Other Practitioners file.